Nurse: Nurse, hello, this is your Astra Star 0215-301-1 visit. I will complete all required source documentation with you. Please confirm your subject initials, subject ID, and today's date. Patient, initials aka subject ID 0215-301, date January 26, 2026. Nurse, visit date is January 26, 2026. Was the visit performed today? Patient, yes, the visit was performed today. Nurse, thank you. We will begin with patient-reported outcomes. Did you complete EQ 5D-5L? Patient, yes. Nurse, did you complete WPAI-GH? Patient, yes. Nurse, did you complete AQL? Patient, yes. Nurse, did you complete ACT? Patient, yes. Nurse, did you complete TQSM? Patient, yes. Nurse, moving to HAE attack diary compliance. Since your last visit, did you complete all weekly diary entries? Patient, yes, all weekly entries were completed. Nurse, were you contacted for all HAE attacks reported since your last visit? Patient, yes. Nurse, any additional notes regarding attacks? Patient, I had two confirmed attacks during run-in. No new attacks since last contact. Nurse, noted. Nurse, adverse events. Were AE's reviewed at this visit? Patient, yes. Nurse, any new adverse events reported? Patient, no new adverse events. Nurse, concomitant medications. Were comeds reviewed? Patient, yes. Nurse, any new or changes to concomitant medications? Patient, no changes. Nurse, inclusion-slash-exclusion criteria. Were all eligibility criteria met, including at least two investigator-confirmed HAE attacks during run-in period? Patient, yes. Nurse, did you continue to meet eligibility a day one visit? Patient, yes. Nurse, randomization. Was the subject randomized in IRT? Patient, yes. Nurse, physical examination pre-dose. Was physical exam completed? Patient, yes. Nurse, time collected 9.45. Now recording vital signs pre-dose. Time at rest 9.40. Time 9.45. Weight 78 kg. Blood pressure 118 over 76 taken on left arm. Heart rate 72 bpm. Temperature 36.8 C. Respiratory rate 16 breaths per minute. Any clinically significant abnormalities? Patient, no. Nurse, PI slash sub-I will review and sign with date January 26, 2026. Nurse, ECG. Was 12 lead ECG performed? Patient, yes. Nurse, date performed January 26, 2026. Time at rest 9.50. Time performed 9.55. Heart rate 72 bpm. PR1 60 millisecond RR 833 millisecond QRS 90 millisecond QT 380 millisecond result normal. Not clinically significant. No abnormalities requiring specification. PI slash sub-I will review and sign dated January 26, 2026. Nurse, laboratory assessments. Were all required labs collected? Patient, yes. Nurse, date collected January 26, 2026. Time collected 9.30. Urine collection time 9.25. Optional pharmacogenetics sample collected? Patient, no. Nurse, reason documented per protocol as optional not consented. Nurse, pregnancy test. Is subject of childbearing potential? Patient, yes. Nurse, was urine sample collected? Patient, yes. Nurse, collection date January 26, 2026. Collection time 9.25. Result negative. Nurse, investigational product administration. Lot number and expiration date verified and recorded in source. Was investigational product administered? Patient, yes. Nurse, prescribed dose 2 mL. Nurse, injection 1. Kit number recorded. Dose administered 2 mL. Anatomical location abdomen. Laterality left lower quadrant. Route subcutaneous. Start date January 26, 2026. Start time 10.05. Was injection interrupted? Patient, no. Nurse, injection 2. Kit number recorded. Dose administered 2 mL. Anatomical location abdomen. Laterality right lower quadrant. Route subcutaneous. Start date January 26, 2026. Start time 10.08. Was injection interrupted? Patient, no. Nurse, unblind staff administration signature and date completed in source. Nurse, physical examination one hour post-dose plus or minus 15 minutes. Was physical exam completed? Patient, yes. Nurse, time collected 1110. Vital signs one hour post-dose. Time at rest 1105. Time 1110. Weight 78 kilograms. Blood pressure 120 over 78 left arm. Heart rate 70 BPM. Temperature 36.7 C. Respiratory rate 16 breaths per minute. Any clinically significant abnormalities? Patient, no. Nurse, PI slash sub-I reviewed dated January 26, 2026. Nurse, participant ID card. Was subject provided with participant ID card? Patient, yes. Nurse, continuing. Will the participant continue in the study? Patient, yes. Nurse, will the participant continue with the treatment period? Patient, yes. Nurse, notes. Mild injection site tenderness after first injection resolved within 20 minutes. No intervention required. Nurse, study coordinator completing source contemporaneously. Signature recorded. Date January 26, 2026. PI reviewed and signed with date January 26, 2026. Nurse, that completes all day one documentation. Do you have any questions? Patient, no questions. Nurse, thank you. Visit complete.